View in EDS HTML Full Text PDF Full Text

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
Authors: McMichael A; Wake Forest University School of Medicine, Winston-Salem, North Carolina., Shahriari M; Yale University School of Medicine, New Haven, Connecticut.; Central Connecticut Dermatology, Cromwell., Stein Gold L; Henry Ford Health System, West Bloomfield, Michigan., Alkousakis T; Johnson & Johnson, Horsham, Pennsylvania., Choi O; Johnson & Johnson, Horsham, Pennsylvania., Bhutani T; Synergy Dermatology, San Francisco, California., Rodriguez AO; Nashville Skin Comprehensive Dermatology Center, Nashville, Tennessee., Tyring SK; Center for Clinical Studies, Webster, Texas.; University of Texas Health Science Center, Houston., Chan D; Johnson & Johnson, Horsham, Pennsylvania., Rowland K; Johnson & Johnson, Horsham, Pennsylvania., Albrecht L; Enverus Medical Research, Surrey, British Columbia, Canada.; University of British Columbia, Vancouver, British Columbia, Canada., Lynde C; The Lynde Institute for Dermatology & Lynderm Research Inc, Markham, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Yadav G; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; FACET Dermatology, Toronto, Ontario, Canada., Yeung J; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Park-Wyllie L; Johnson & Johnson, Toronto, Ontario, Canada., Ma T; Johnson & Johnson, Spring House, Pennsylvania., Jeyarajah J; Johnson & Johnson, Spring House, Pennsylvania., Gao LL; Johnson & Johnson, Spring House, Pennsylvania., Smith S; California Dermatology & Clinical Research Institute, Encinitas., Moore AY; Baylor University Medical Center, Dallas, Texas.; Arlington Research Center, Arlington, Texas., Vashi N; Boston University School of Medicine, Boston, Massachusetts., Kindred C; Kindred Hair & Skin Center, Marriottsville, Maryland.; Howard University College of Medicine, Washington, DC., Grimes P; The Grimes Center for Medical and Aesthetic Dermatology, Vitiligo and Pigmentation Institute of Southern California, Los Angeles., Desai SR; Innovative Dermatology, Plano, Texas.; University of Texas Southwestern Medical Center, Dallas., Taylor SC; University of Pennsylvania, Philadelphia., Alexis A; Weill Cornell Medicine, New York, New York.
Corporate Authors: VISIBLE Trial Investigators
Source: JAMA dermatology [JAMA Dermatol] 2025 Sep 01; Vol. 161 (9), pp. 912-922.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40560554
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McMichael+A%22">McMichael A</searchLink>; Wake Forest University School of Medicine, Winston-Salem, North Carolina.<br /><searchLink fieldCode="AU" term="%22Shahriari+M%22">Shahriari M</searchLink>; Yale University School of Medicine, New Haven, Connecticut.; Central Connecticut Dermatology, Cromwell.<br /><searchLink fieldCode="AU" term="%22Stein+Gold+L%22">Stein Gold L</searchLink>; Henry Ford Health System, West Bloomfield, Michigan.<br /><searchLink fieldCode="AU" term="%22Alkousakis+T%22">Alkousakis T</searchLink>; Johnson & Johnson, Horsham, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Choi+O%22">Choi O</searchLink>; Johnson & Johnson, Horsham, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Bhutani+T%22">Bhutani T</searchLink>; Synergy Dermatology, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rodriguez+AO%22">Rodriguez AO</searchLink>; Nashville Skin Comprehensive Dermatology Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Tyring+SK%22">Tyring SK</searchLink>; Center for Clinical Studies, Webster, Texas.; University of Texas Health Science Center, Houston.<br /><searchLink fieldCode="AU" term="%22Chan+D%22">Chan D</searchLink>; Johnson & Johnson, Horsham, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Rowland+K%22">Rowland K</searchLink>; Johnson & Johnson, Horsham, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Albrecht+L%22">Albrecht L</searchLink>; Enverus Medical Research, Surrey, British Columbia, Canada.; University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Lynde+C%22">Lynde C</searchLink>; The Lynde Institute for Dermatology & Lynderm Research Inc, Markham, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yadav+G%22">Yadav G</searchLink>; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; FACET Dermatology, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yeung+J%22">Yeung J</searchLink>; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Park-Wyllie+L%22">Park-Wyllie L</searchLink>; Johnson & Johnson, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ma+T%22">Ma T</searchLink>; Johnson & Johnson, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Jeyarajah+J%22">Jeyarajah J</searchLink>; Johnson & Johnson, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Gao+LL%22">Gao LL</searchLink>; Johnson & Johnson, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Smith+S%22">Smith S</searchLink>; California Dermatology & Clinical Research Institute, Encinitas.<br /><searchLink fieldCode="AU" term="%22Moore+AY%22">Moore AY</searchLink>; Baylor University Medical Center, Dallas, Texas.; Arlington Research Center, Arlington, Texas.<br /><searchLink fieldCode="AU" term="%22Vashi+N%22">Vashi N</searchLink>; Boston University School of Medicine, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kindred+C%22">Kindred C</searchLink>; Kindred Hair & Skin Center, Marriottsville, Maryland.; Howard University College of Medicine, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Grimes+P%22">Grimes P</searchLink>; The Grimes Center for Medical and Aesthetic Dermatology, Vitiligo and Pigmentation Institute of Southern California, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Desai+SR%22">Desai SR</searchLink>; Innovative Dermatology, Plano, Texas.; University of Texas Southwestern Medical Center, Dallas.<br /><searchLink fieldCode="AU" term="%22Taylor+SC%22">Taylor SC</searchLink>; University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Alexis+A%22">Alexis A</searchLink>; Weill Cornell Medicine, New York, New York.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22VISIBLE+Trial+Investigators%22">VISIBLE Trial Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2025 Sep 01; Vol. 161 (9), pp. 912-922.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40560554
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2025.1849
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 912
    Titles:
      – TitleFull: Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McMichael A
      – PersonEntity:
          Name:
            NameFull: Shahriari M
      – PersonEntity:
          Name:
            NameFull: Stein Gold L
      – PersonEntity:
          Name:
            NameFull: Alkousakis T
      – PersonEntity:
          Name:
            NameFull: Choi O
      – PersonEntity:
          Name:
            NameFull: Bhutani T
      – PersonEntity:
          Name:
            NameFull: Rodriguez AO
      – PersonEntity:
          Name:
            NameFull: Tyring SK
      – PersonEntity:
          Name:
            NameFull: Chan D
      – PersonEntity:
          Name:
            NameFull: Rowland K
      – PersonEntity:
          Name:
            NameFull: Albrecht L
      – PersonEntity:
          Name:
            NameFull: Lynde C
      – PersonEntity:
          Name:
            NameFull: Yadav G
      – PersonEntity:
          Name:
            NameFull: Yeung J
      – PersonEntity:
          Name:
            NameFull: Park-Wyllie L
      – PersonEntity:
          Name:
            NameFull: Ma T
      – PersonEntity:
          Name:
            NameFull: Jeyarajah J
      – PersonEntity:
          Name:
            NameFull: Gao LL
      – PersonEntity:
          Name:
            NameFull: Smith S
      – PersonEntity:
          Name:
            NameFull: Moore AY
      – PersonEntity:
          Name:
            NameFull: Vashi N
      – PersonEntity:
          Name:
            NameFull: Kindred C
      – PersonEntity:
          Name:
            NameFull: Grimes P
      – PersonEntity:
          Name:
            NameFull: Desai SR
      – PersonEntity:
          Name:
            NameFull: Taylor SC
      – PersonEntity:
          Name:
            NameFull: Alexis A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 161
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1